OMRF scientist Scott Plafker has received a four-year grant from the NIH to study whether a natural compound can help prevent a common eye disease.
For nearly 20 percent of MS patients, vision loss is the first symptom.
Awards “a testament to the quality of research in Oklahoma”
Scott and Kendra Plafker are still achieving firsts after 17 years of marriage.
The discovery could lead to better understanding of insulin resistance.